Trazodone Hydrochloride
Phase 2Small molecule
Trazodone Hydrochloride is one of 2 small molecule programs targeting OSA. It is currently in Phase 2.
1
Indications
7
Total Trials
2
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in OSA
#DrugCompanyPhaseTrials
1Lunesta
Akero TherapeuticsPhase 2
Trazodone Hydrochloride
LLee's Pharmaceutical Limited
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Prolonged2 trials
Major Depressive Disorder1 trial
OSA1 trial
Trazodone on OSA Endotypes
Recruiting·—·Phase 1/2·NCT06286189·18 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Trazodone Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- LLee's Pharmaceutical Limited